Patients with lower socioeconomic status also have increased probability of functional decline in longitudinal analyses
TUESDAY, Aug. 24, 2021 (HealthDay News) — Worse functional status and increased probability of functional decline are seen for patients with rheumatoid arthritis (RA) with lower socioeconomic status (SES), according to a study published online Aug. 4 in JAMA Network Open.
Zara Izadi, M.Pharm., from the University of California in San Francisco, and colleagues examined the association between SES and functional status in patients with RA using data from the American College of Rheumatology’s Rheumatology Informatics System for Effectiveness registry. Data were included for 83,965 patients with a confirmed RA diagnosis who were seen at participating rheumatology practices.
The researchers found that the mean functional status score was worse at lower SES levels for all measures (e.g., Multidimensional Health Assessment Questionnaire quintile 1 and 5: 1.79 and 2.43, respectively). The probability of functional decline was 14.1 and 18.9 percent in the highest and lowest SES quintile, respectively, in longitudinal analyses. Disease activity partially mediated the association between SES and functional decline (7 percent).
“We found important disparities in functional status by SES in a national cohort of individuals with RA, despite utilization of rheumatology care,” the authors write. “Future qualitative research is important to further our understanding of factors that affect functional status, including factors outside of medical care that can be intervened on.”
Several authors disclosed financial ties to the pharmaceutical industry.
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported
Socioeconomic Status Linked to Mortality After Acute Hip Fracture Surgery
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season
Trends Reported in Vaccination Coverage for Adolescents for 2025
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder